#	Pagina
attuale pagina	/open-h2020/projects/207164/index.html
-1	/open-h2020/per-topic/actar/list/index.html
-2	/open-h2020/projects/217240/index.html
-3	/open-h2020/projects/226837/index.html
-4	/open-h2020/projects/217302/index.html
-5	/open-h2020/projects/225178/index.html
-6	/open-consip/fornitori/2015/profilo-00565100708/index.html
-7	/open-fp7/projects/98317/index.html

Opendata, web and dolomites

PaDiCare

Patient empowered Diabetes care in ambulatory settings

Total Cost €

EC-Contrib. €

Partnership

Views

Outcomes and
results

PaDiCare project word cloud

Explore the words cloud of the PaDiCare project. It provides you a very rough idea of what is the project "PaDiCare" about.

source tablet appointments ambulatory share diseases bottleneck care assays collects rooms turnover drop runs procedure hba1c diabetes monitoring point finger poc epr draw efficiency option efficient helps expand record saving doctors introduction trips atonomics clinicians accessibility trace simplified hospital doctor combines analysing market grade diabetic sync performing secure daily min automatically synced mellitus infrastructure waiting chronic biomarker benefit joint blood labs guided perform assay platform glucose data panel proper hours dm regular lipid app time services electronic staff itc4u intelecare4u pc accurate opentele involvement sustainability nurses transmits collected faster pricking patient device syncs biomarkers precise hospitals lab resource patients vision run

Project "PaDiCare" data sheet

The following table provides information about the project.

Coordinator	ATONOMICS AS Organization address address: VESTRE TEGLGADE 10 city: KOBENHAVN postcode: 2750 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.
Coordinator Country	Denmark [DK]
Project website	http://www.padicare.com
Total cost	71˙429 €
EC max contribution	50˙000 € (70%)
Programme	1. H2020-EU.3.1.4. (Active ageing and self-management of health) 2. H2020-EU.2.1.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT)) 3. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument) 4. H2020-EU.3.1.6. (Health care provision and integrated care)
Code Call	H2020-SMEINST-1-2016-2017
Funding Scheme	SME-1
Starting year	2016
Duration (year-month-day)	from 2016-11-01 to 2017-03-31

Partnership

Take a look of project's partnership.

#	participants	country	role	EC contrib. [€]
1	ATONOMICS AS ATONOMICS AS Organization address address: VESTRE TEGLGADE 10 city: KOBENHAVN postcode: 2750 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	DK (KOBENHAVN)	coordinator	50˙000.00
2	INTELECARE4U APS INTELECARE4U APS Organization address address: EUROPAPLADS 16 city: AARHUS C postcode: 8000 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	DK (AARHUS C)	participant	0.00

Map

Project objective

Atonomics and InTeleCare4U’s joint vision is to bring Trace to market, a Point-of-Care (POC) blood biomarker monitoring system for Diabetes Mellitus (DM) that syncs highly accurate and precise lab results to hospital’s electronic patient record (EPR). Trace has such a simplified user experience that patients can perform their own blood analysis without nurses performing the blood draw or lab staff analysing the sample. Trace analysis require just a drop of blood obtained through finger-pricking, the same procedure that diabetic patients use for daily glucose monitoring. Analysis runs automatically in a very short time (5-7 min per biomarker) and the results are then synced to doctors’ PC / tablet through ITC4U’s data sync services – based on the open source OpenTele platform. Trace system combines the following three key elements for effective and resource-efficient monitoring: - Trace device, an easy to use, lab-grade device to measure HbA1c and lipid panel biomarkers for DM monitoring; - Trace tablet app, a step-guided application that helps patients use the Trace device, and collects the results from Trace; - ITC4U’s secure sync infrastructure that transmits patient data collected in app directly to the doctor’s tablet or PC.

With the growing share of DM patients, the availability of clinicians will become a bottleneck for proper care. Patient involvement in these analyses is the best option for sustainability of care. Trace addresses this market. The short assay run time means that patients can perform blood analysis just before their regular appointments, already at the ambulatory unit, saving hours in waiting rooms and trips to labs. Hospitals benefit from faster patient turnover, providing care to more patients with the same resources (i.e. higher efficiency and higher care accessibility). Over time, Trace will be able to expand biomarker monitoring to other chronic diseases, through the development and market introduction of further assays for Trace.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PADICARE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "PADICARE" are provided by the European Opendata Portal: CORDIS opendata.